Translation and Validation of the Abbey Pain Scale in Stroke Patients (ABBEY-F)

Only registered users can translate articles

The link is saved to the clipboard

StatusNot yet recruiting

Keywords

Abstract

Pain is common after a stroke, affecting up to 49% of patients within 2 years of the event. They include headache, musculoskeletal pain, spasticity and central neuropathic pain. A wide range of patients have communication problems after stroke that make it difficult to assess pain. Yet there is a major impact of pain on the quality of life of these patients. Some tools have been validated to assess pain in non-communicative patients, but none are specific to stroke patients. The Algoplus scale is commonly used in intra-hospital care in France. The Abbey Pain Scale is not translated into French, and could provide a more accurate pain rating for non-communicative patients.

The objective is to validate a French version of the Abbey Pain Scale for stroke patients.

It is an observational study with longitudinal data collection. It is planned to include 120 patients from the neurology department of the Clermont-Ferrand University Hospital.

Description

The study will be conducted over a 12-month period. 120 patients hospitalized for stroke including 60 communicating and 60 non-communicating patients will be recruited. Epidemiological data will be collected at enrollment, as well as an initial assessment using the Abbey and Algoplus scales for non-communicating and communicating patients, and also the numerical scale for communicating patients. The HADS questionnaire will be completed by communicating patients only. Of the 60 patients in each group, 30 will receive a second concurrent assessment by an inter-rater, 30 will receive a test/retest reassessment after 30 minutes, and 20 will be reassessed 90 minutes later by the same scales after pain treatment. For 30 of the 120 patients, an infrared pupillometry measurement will be performed before and after treatment of acute pain. All patients will be recruited from the neurovascular unit of the Clermont-Ferrand University Hospital.

Dates

Last Verified:	06/30/2020
First Submitted:	07/19/2020
Estimated Enrollment Submitted:	07/19/2020
First Posted:	07/22/2020
Last Update Submitted:	07/19/2020
Last Update Posted:	07/22/2020
Actual Study Start Date:	08/31/2020
Estimated Primary Completion Date:	08/31/2021
Estimated Study Completion Date:	09/30/2021

Condition or disease

Stroke

Pain

Intervention/treatment

Diagnostic Test: Abbey Pain Scale

Phase

Arm Groups

Arm	Intervention/treatment
non-communicant stroke patients Patients suffering from stroke, and unable to efficient communication. They will be assessed for pain through several tools (hetero-assessment of pain).
communicant stroke patients Patients suffering from stroke, and unable to efficient communication. They will be assessed for pain through several tools (including hetero-assessment and auto-assessment of pain)

Eligibility Criteria

Ages Eligible for Study	18 Years To 18 Years
Sexes Eligible for Study	All
Sampling method	Non-Probability Sample
Accepts Healthy Volunteers	Yes
Criteria	Inclusion Criteria: - at least 18 years old ; - Covered by Social Security; - Hospitalized in the Neurovascular Unit for the management of ischemic stroke with or without reperfusion treatment, or hemorrhagic stroke; - NIHSS score greater than 1; - For communicating patients: French mother tongue, or reading French without assistance, and able to understand the objectives. Exclusion Criteria: - Refusal ; - Legally protected patient - Pregnancy; - Pre-stroke psychiatric or neurodevelopmental disorders; - Transient ischemic attack; - Specific strokes: Bithalamic, locked-in syndrome.

Outcome

Primary Outcome Measures

1. Abbey Pain Hetero-Evaluation Scale [day 0]

This scale searches for elements suggestive of pain in the patient by scoring between 0 (absent) and 3 (severe) each of the items: vocalization, facial expression, body language, physiological modifications, physical modifications; obtaining a score between 0 and 18.

Secondary Outcome Measures

1. Hospital Anxiety Depression Scale (HADS) Questionnaire [day 0]

This scale is an instrument to screen for anxiety and depressive disorders. It consists of 14 items rated from 0 to 3. Seven questions relate to the anxiety dimension (total A) and seven others to the depressive dimension (total D), giving 2 scores. for communicant patients only

2. Algoplus Pain Hetero-Evaluation Scale [day 0]

This scale searches for elements suggestive of pain in the patient by answering YES/NO to each of the items: face, gaze, complaints, body, and behaviour; score between 0 and 5.

3. Numerical Scale [day 0]

This is a communicant patient's self-assessment of the intensity of pain felt, between 0 (no pain) and 10 (maximum pain). for communicant patients only

4. Infrared pupillometry measurement [day 0 before treatment of acute pain]

It is an absolute measurement of pupil size using a portable pupillometer

5. Infrared pupillometry measurement [day 0 after treatment of acute pain]